It is our pleasure to invite you to the 2nd ISC International
Conference on Cancer Therapeutics, Molecular Therapeutics
and Clinical Applications to be held in İstanbul, Turkey on
November 10 - 12, 2005.
This will be the second of a series of important annual scientific
meetings to be held jointly by the International Society of
Chemotherapy and national chemotherapy societies in various
countries. As you will remember, the first conference has
already been organized in Italy in February 2004.
It is well known that cancer chemotherapy has been empirical
for many years. The drugs used for that purpose are mainly
DNA poisons and in that sense they are rather nonspecifical.
However after the progresses acquired in molecular biology
and in molecular chemistry, the last decade has seen the arrival
of quite a number of new substances aiming at targets on cancer
cells. We can mention the monoclonal antibodies in aiming
at the surface ligands of various receptor families, the small
molecules inhibiting the intracellular cascade of signal conduction,
such as tyrosine kinase and ras-map kinase pathways, the exploitation
of cytokines, anti-angiogenic approaches and anti-tumoral
vaccines, to mention just a few.
In addition to these avant-garde acquisitions, many new drugs
that have been on the market such as Platin salts, Gemcitabin,
Taxanes, Etoposide, Navelbin, Irinotecan, etc. are still in
research with various new combinations and new indications
in clinical research. And this is still an ongoing subject
As it is easily seen, there is so much work to do either on
basic science and on clinical science, that meetings like
this one have an important place in investigational and educational
The Conference will have symposia organized by leading scientists
on the above summarized topics as well as sessions of proffered
papers and posters which will bring new findings to our meeting.
As you will agree, Istanbul will be a very appropriate place
for the set-up of such an international meeting.
We hope you will join us in the ISC Conference on Cancer
On behalf of the Organizing Committee
Prof. Dr. Bülent Berkarda